PHARMACEUTICAL COMPOSITION FOR BONE-DISEASE TREATMENT OR COUNTERING INFLAMMATION, COMPRISING CARTILAGE STEM CELLS AS AN ACTIVE PRINCIPLE

摘要

The present invention relates to a pharmaceutical composition for bone-disease treatment or countering inflammation, comprising cartilage stem cells as an active principle. The present invention provides a novel cell treatment regimen for bone disease and inflammatory disease using cartilage stem cells as an active principle. When the cartilage stem cells of the present invention are administered into a joint capsule, the administered cartilage stem cells are highly effective in treating bone disease and inflammatory bone disease since they grow or differentiate into cartilage cells and exhibit an anti-inflammatory action at the administration site. In that there is no expression of histocompatibility antigens which give rise to rejection reactions in tissue and organ transplants, the cartilage stem cells of the present invention have the advantage that they allow autologous cells and exogenous cells to be used during cell transplantations for bone disease and anti-inflammation treatment.